Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-011061
Filing Date
2019-11-14
Accepted
2019-11-14 16:27:43
Documents
107
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zcor-20190930x10q.htm 10-Q 3707742
2 EX-10.3 zcor-20190930ex103689090.htm EX-10.3 169548
3 EX-10.5 zcor-20190930ex1053eb866.htm EX-10.5 279652
4 EX-31.1 zcor-20190930ex311ec9d8b.htm EX-31.1 17303
5 EX-31.2 zcor-20190930ex312a83a33.htm EX-31.2 16799
6 EX-32.1 zcor-20190930ex321beca61.htm EX-32.1 8863
7 EX-32.2 zcor-20190930ex32219e881.htm EX-32.2 8357
  Complete submission text file 0001558370-19-011061.txt   15673443

Data Files

Seq Description Document Type Size
8 EX-101.INS zcor-20190930.xml EX-101.INS 3805800
9 EX-101.SCH zcor-20190930.xsd EX-101.SCH 95764
10 EX-101.CAL zcor-20190930_cal.xml EX-101.CAL 93941
11 EX-101.DEF zcor-20190930_def.xml EX-101.DEF 373481
12 EX-101.LAB zcor-20190930_lab.xml EX-101.LAB 741103
13 EX-101.PRE zcor-20190930_pre.xml EX-101.PRE 644505
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Zyla Life Sciences (Filer) CIK: 0001586105 (see all company filings)

EIN.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36295 | Film No.: 191220798
SIC: 2834 Pharmaceutical Preparations